STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.
Also called NCT05785897
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 350 participants
- Sponsor
- IGLESIAS Juan Fernando
- Registry
-
NCT05785897
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT05785897. Randomized; single masking; primary purpose treatment. Start 2025-11-01 (actual); primary completion 2027-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
- Acronym
- STARS DAPT
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Device)
- Successful primary PCI (percutaneous coronary intervention), defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
- Lead sponsor
- IGLESIAS Juan Fernando
- Collaborator
- Clinical Trials Unit University of Bern
Record details
- Record id
cardio:ct-nct05785897- Content hash
f28b15b405cb9de33d704cf8d4203b5bb663fc05df1854887801e8f617e6f4e2